Evaluation of the effectiveness of prolotherapy on patients with knee osteoarthritis

Not Applicable

• Conditions: Condition 1: arthrosis of knee. Condition 2: arthrosis of knee.; Primary gonarthrosis, bilateral; Other primary gonarthrosis

• Registration Number: IRCT2016091229795N1
• Lead Sponsor: Department of Physical Medicine and Rehabilitation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

inclusion croteria: patient had these symptoms atleast for 1 month joint stiffness; criptation; knee pain.
exclusion criteria: any intra or extra knee jonit injection in past 3 months; total knee arthroplasty; lumbo sacral radiculopathy; uncontrolled diabetic mellitus with HbA1C more than7.5; reumatic disorders such as rheumatoid arthritis,goat, SLE, brucella; knee truma during 3 months ago; knee fracture during 3 months ago; BMI more than 42.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: befor injection, 2 and 4 weeks after injection. Method of measurement: Visual Analog Scale( VAS).;Patient function. Timepoint: befor injection and 2 and 4 weeks after injection. Method of measurement: The WOMAC consists of 24 items divided into 3 subscales:Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing.Stiffness (2 items): after first waking and later in the day.Physical Function (17 items): stair use, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy household duties, light household duties.